Malaria medicine 'Hydroxychloroquine' being administered to 1,100 COVID19 patients in NY

Malaria medicine 'Hydroxychloroquine' being administered to 1,100 COVID19 patients in NY

Malaria medicine 'Hydroxychloroquine' being administered to 1,100 COVID19 patients in NY

"Although there are no now approved treatments for COVID-19, both drugs have shown activity in laboratory studies against coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19)", the statement added.

Last week, French health authorities permitted the use of the anti-malarial drug chloroquine to treat COVID-19 patients who are in serious condition and under strict medical supervision.

The FDA has already given NY state permission to give desperately ill patients a cocktail of hydroxychloroquine and azithromycin on a "compassionate care" basis.

"Let's see how it works", Trump said at a press briefing on Sunday, referencing NY state's efforts.

"But because this is just a single statistic we can not say that chloroquine and azithromycin works for Covid-19". "Hydroxychloroquine & Azithromycin, taken together, have a real chance to be one of the biggest game changers in the history of medicine", he tweeted Saturday.

Stressing that Trump is "taking every possible step" to protect the citizens, HHS Secretary Alex Azar said, "Scientists in America and around the world have identified multiple potential therapeutics for COVID-19, including chloroquine and hydroxychloroquine". "Let's see how it may work or may not, but we may have some incredible results".

President Trump has spoken out about the importance of trying new treatments in hopes that we can learn where there's room for optimism and where there is not.

On Sunday, the US Department of Health and Human Services (HHS) issued a statement noting that the US Food and Drug Administration (FDA) had given authorization for hydroxychloroquine and chloroquine to be used to treat hospitalized patients.

The government banned export of hydroxychloroquine on March 25 and two days later, to prevent its misuse and restrict sales, changed its categorisation as a Schedule H1 drug, meaning hydroxychloroquine could only be sold on prescription. The statement also announced that Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine.

Several countries are conducting clinical trials for the drugs as part of their campaigns to quell the COVID-19 pandemic. Johns Hopkins reported late Sunday that there were 721,000 cases worldwide and 142,000 cases in the U.S.

Related news

[an error occurred while processing the directive]